Specialty Pharmacy

As population health management becomes increasingly critical, health-system pharmacists should reacquaint themselves with the factors driving patient outcomes.

CVS Health is looking into a claim that one of its pharmacies in Texas dispensed the wrong medication to a woman more than once.

Aggressive new approaches considered to curb financial hit from prescription drugs.

Severity and type of symptoms varies among cancer patients in different age groups.

Continued steroid use associated with worse anxiety, sleep, and fatigue.

Average MS onset for patients who spent time in the sun every day is nearly two years later than patients who did not spend daily time in the sun.

REMS deemed unnecessary to ensure drug benefits outweigh risks.

Traveling a longer distance to a medical center was not associated with spending more time on a waiting list.

C-reactive protein is useful in the diagnosis and treatment of some acute or chronic inflammatory conditions.

Out-of-pocket costs to remain a significant hurdle for patients even after closing of coverage gap.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the trend of larger entities absorbing independent specialty pharmacies.

Prescription drugs costs for patients with psoriatic arthritis tended to be higher than comparable costs for ankylosing spondylitis.

A report by STAT has found that a majority of institutions conducting clinical trials fail to report their results to the web site ClinicalTrials.gov.

Fatigue had a strong association with pain intensity and interference in inflammatory bowel disease.

Patients who receive an overdose of chemotherapy drugs will now have access to an emergency treatment called uridine triacetate.

Bendeka was approved for indolent B-cell non-Hodgkin lymphoma that progressed during or within 6 months of treatment with a rituximab regimen.

Researchers weigh risk and reward in starting early antiretroviral therapy in patients with HIV.

Liver conserving treatments are sorely needed.

Patients with chronic conditions like HIV and hepatitis C could no longer be denied coverage due to pre-existing conditions under the ACA.

Prolonged steroid treatment may put inflammatory bowel disease patients at greater risk for steroid-associated adverse events.

Test diagnoses RA with better accuracy by detecting synthetic citrullinated peptides.

LQG participants show improvements in lung function, overall health, mental health, and quality of life.

Diabetes has a tremendous global impact, but developing nations often struggle to help patients deal with their disease.

Trial data shows positive results across a range of difficult-to-treat patients with MM.

Amy Grogg, PharmD, senior vice president of Strategy and Commercialization at AmerisourceBergen Specialty Group, discusses developing trends in specialty drug cost management.

Research may lead to gel that prevents transmission of HIV, hepatitis C and the Ebola virus.

HIMSS is working to determine the readiness of providers to participate in the types of value-based payment models that CMS is moving toward.

Researchers examine impact of probiotics on inflammatory bowel disease.